Zusduri™
(mitomycin) for intravesical solution
ZUSDURI is an FDA-approved treatment for adult patients with recurrent low-grade intermediate-risk non-muscle invasive bladder cancer (LG-IR-NMIBC).
ZUSDURI is an FDA-approved treatment for adult patients with recurrent low-grade intermediate-risk non-muscle invasive bladder cancer (LG-IR-NMIBC).